Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB
Clinical trial NCT01751568 · COMPLETED
Trial details
- NCT number
- NCT01751568
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-12
- Primary completion
- 2019-11-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.